A pilot, single arm, single center study to determine the feasibility of obtaining stool samples from adult patients receiving SBRT to a lung tumor, if SBRT induces changes in the gut microbiota and to obtain preliminary data about possible correlation of baseline composition and changes in gut microbiota with tumor response, local control, and development of pneumonitis/other side effects.
Study Type
OBSERVATIONAL
Enrollment
10
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Number of subject providing stool samples
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.